Evidence map›Paper›PMID 30140615›Full record

ArticleToxicology reports2018

A comparison of the anti-diabetic potential of d-ribose-l-cysteine with insulin, and oral hypoglycaemic agents on pregnant rats.

Abraham A A Osinubi, Leke Jacob Medubi, Edidiong N Akang, Lawal K Sodiq, Titilola A Samuel, Taiwo Kusemiju, James Osolu, Danladi Madu, Olufemi Fasanmade

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Abraham A A OsinubiDepartment of Anatomy, College of Medicine of the University of Lagos, Lagos, Nigeria.
Leke Jacob MedubiDepartment of Anatomy, College of Medicine of the University of Lagos, Lagos, Nigeria.
Edidiong N AkangDepartment of Anatomy, College of Medicine of the University of Lagos, Lagos, Nigeria.
Lawal K SodiqDepartment of Anatomy, College of Medicine of the University of Lagos, Lagos, Nigeria.
Titilola A SamuelDepartment of Biochemistry, College of Medicine of the University of Lagos, Lagos, Nigeria.
Taiwo KusemijuDepartment of Anatomy, College of Medicine of the University of Lagos, Lagos, Nigeria.
James OsoluAjah Primary Healthcare Centre, Eti-Osa East, LCDA, Lekki, Lagos, Nigeria.
Danladi MaduDepartment of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria.
Olufemi FasanmadeDepartment of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria.
University of Lagos · NGLagos University Teaching Hospital · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over 18% of pregnant women are affected by diabetes mellitus (DM) and Insulin has been the commonest drug used in its treatment. There are reports of noncompliance to insulin due to trypanophobia, with suggestions for the use of oral hypoglycaemic agents (OHAs). However, the opposing views about the benefits and risk of oral hypoglycaemic agents (OHAs) warrant a continuous search for an alternative regimen. Therefore, this study is aimed at comparing the antidiabetic effects of d-ribose-l-cysteine (riboceine) with vildagliptin, glibenclamide, metformin, glipizide and insulin in diabetes in pregnancy. Forty (40) female Sprague-Dawley (SD) rats were mated with twenty (20) male SD rats. Diabetes was induced by streptozotocin and the female SD rats were divided into 8 groups of five (5) rats each. The animals were administered either of the OHAs vildagliptin, glibenclamide, metformin, glipizide and riboceine for a period of 19 gestational days. The results showed that streptozotocin (STZ) significantly (

Indexed as

Diabetesd-Ribose-l-CysteineGlibenclamideGlipizideMetforminOxidative stressVildagliptin

Identifiers

PMID30140615
PMCPMC6104459
OpenAlexW2886795253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.